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Summary The folates present in liver, gut and tumour tissue were examined before and after autolysis.
Before autolysis 10-formylfolate tetraglutamate (10-CHOFA(glu)4), 5-methyltetrahydrofolate triglutamate (5-
CH3THF(glu)3) and possibly tetrahydrofolate polyglutamate(s) (THF(glu)n) were detected. Liver contained all
3 species whereas no 5-CH3THF(glu)3 was present in the tumours; gut showed an intermediate situation.
After autolysis the predominant monoglutamates formed were 5-CH3THF in the liver, 10-formylfolates in the
gut and possibly tetrahydrofolate (THF) in the tumour extracts. These differences illustrate changes in tissue
folates with the proliferation rate of the tissue and suggest an explanation for the methionine auxotrophy of
Walker 256 carcinosarcoma cells.
Folate-dependent reactions are centrally involved in
the biosynthetic pathways critical for cell replication
and there are a number of reports in the literature
of the differing patterns of folate co-enzymes
exhibited by rapidly dividing tissues compared to
resting tissues. These include studies on neoplasms
(Sotobayashi et al., 1966) and on normal
proliferating tissue (Barbiroli et al., 1975). Overall,
the results show a shift from 5-
methyltetrahydrofolate (5-CH3THF) to
formylfolates in the rapidly-dividing tissue.
The major naturally-occurring tissue folates are
polyglutamate conjugates (Whitehead, 1971) and
changes in the glutamyl chain length have also been
suggested to coincide with an increase in cellular
proliferation. Krumdiek et al. (1976) described
changes in the ratio of monoglutamyl-to-
polyglutamyl folate in the uteri of rats at different
stages of the oestrus cycle and suggested that the
increase in free folate (i.e. monoglutamate
derivatives) at proestrus may be connected with the
increase in uterine cell growth at this stage.
Whitehead (1973) and Marchetti et al. (1980)
reported a shift from high chain length forms to
mono-and triglutamate forms in regenerating rat
liver but Lavoie et al. (1975) were unable to confirm
this finding.
Studies of the folate-dependent enzymes in liver
and a number of hepatomas have shown that the
activity of the majority of these enzymes is lower in
the hepatomas (Lepage et al., 1972). Thymidylate
synthetase is a notable exception, its activity being
considerably greater (Jackson & Niethammer, 1979).
Other studies indicate that the folate-requiring
enzymes involved directly or indirectly with nucleic
acid synthesis show maximal activity in dividing
cells (Rosenblatt & Erbe, 1973; Johnson et al., 1978;
Rode et al., 1979; Rowe et al., 1979). These
enzymatic changes would be expected to result in a
displacement in the equilibrium between the various
coenzymes.
In this investigation the folates present in liver (a
slow-growing tissue), gut (a rapidly-growing normal
tissue) and tumour tissue were compared. Two
approaches were used; (a) the tissues were allowed
to autolyse and the resulting monoglutamates
studied; (b) direct analysis of the folates present in
the different tissues was performed.
Materials and methods
Tissue autolysis experiments
Normal and tumour-bearing male rats (Chester
Beatty Wistars) in groups of 3, were given p.o. a
mixture of 2yuCi 2-[14C]- and 5yuCi 3', 5', 7,-[3H)
folic acid (10OIgkg-' body wt.) and maintained in
cages designed to prevent coprophagy with free
access to food and water. Forty-eight hours after
administration of the labelled folic acid the animals
were killed and the livers, whole gut tissue or
tumours removed, chilled and homogenised in
0.25 M-sucrose/0.05 M sodium phosphate buffer, pH
7.0 containing 2.0% (w/v) sodium ascorbate. The
homogenates were centrifuged at 4°C for h at
100,000 g and the resulting cytosol fraction was
used in the subsequent incubations.
Samples of cytosol (5-10ml) were allowed to
autolyse at 37°C for various times (0-2h). The
reaction was stopped by heating to 100°C for
5min., cooling and centrifuging to remove
precipitated protein. The supernatant was then
sequentially chromatographed on Sephadex G15
and DEAE-cellulose.
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Identification oftissuefolates
Normal and tumour-bearing rats (Chester Beatty or
WAB/NOT Wistars) were given p.o. a mixture of
2yiCi 2-[14C] and 5 jCi 3',5',7,9-[3H]-folic acid
(80jigkg-1 body wt.) and kept in cages as above.
At various times (2h-11 days) after administration,
rats were killed in pairs and the tissues under
investigation removed and extracted in hot 0.05M
sodium phosphate buffer, pH 7.0, containing 2%
(w/v) sodium ascorbate as described by Barford et
al. (1977). Analysis of tissue extracts was carried out
using sequential Sephadex G15 and DEAE-cellulose
chromatography. Isolated fractions were examined
by HPLC.
Animals
Chester Beatty Wistar rats were supplied by Mr B.
Mitchley, Chester Beatty Research Institute,
Institute of Cancer Research London. Tumours
were initiated by s.c. injections of 2 x 106 Walker
256 carcinosarcoma ascitic cells into the right flank
and the animals used one week later.
WAB/NOT Wistar rats were supplied by Dr
M.V. Pimm, University of Nottingham. Animals
received s.c. trocar implantation of fragments of the
MC103B sarcoma (Pimm et al., 1980) on the right
flank. The tumour mass was allowed to grow for 2-
3 weeks before experimentation.
Determination ofradioactivity
Column effluents were counted as described by
Connor et al. (1979).
Column chromatography
Sephadex G15 gel filtration and DEAE-cellulose
chromatography (using linear gradients of 0-
1.2 M NaCI in 0.05 M sodium phosphate buffer, pH
7.0) were performed as described by Barford et al.
(1977). In certain cases fractions from Sephadex
GI5 columns were collected into 1 ml sodium
ascorbate (2% w/v) to prevent oxidation of labile
folates.
High performance liquid chromatography (HPLC)
HPLC was carried out on a Partisil anion-exchange
column (M9, 10/50 SAX, 10mm x 50cm) using 2
LDC constametric pumps controlled by a LDC
gradient master. Folate markers were detected by
their U.V. absorbance at 280 nm using a LDC
spectro monitor (Model III). Prior to loading onto
HPLC (sample loop injection, 2ml) samples were
filtered (0.22 jim Millipore) and adjusted to pH 4.5.
Column elution was affected over 1 h with a flow
rate of 1 mlmin-1 using a linear Na2SO4 gradient
(0-0.5 M) in 0.05 M sodium phosphate buffer (pH.
4.5) containing dithiothreitol (5mg%0). On
completion of gradient time (1 h), elution was
continued at maximum salt concentration for an
additional hour. Where appropriate, fractions (2ml)
were collected and the total radioactivity in each
one determined. The retention times of various
folate derivatives under these conditions are given
in Table I. Unlike the other columns, this method
also separates folate polyglutamates differing in the
number of glutamate residues.
Table I Retention times of folate
derivatives on HPLC
Folate monoglutamates: R,(min)
FA 48
10-CHOTHF 30
10-CHOFA 42
5-CH3THF 44
5-CHOTHF 46
Folact polvglutamates
FA(glU)3 66
FA(glu)4 77
FA(glu), 82
10-CHOFA(glu)3 61
10-CHOFA(glu)4 67
10-CHOFA(glu), 75
5-CH3THF(glu)3 71
5-CH3THF(glu)4 75
Abbreviations used: THF
=tetrahydrofolate, FA=folic acid; 10-
CHOTHF= 10-formyltetrahydrofolate;
1O-CHOFA = 10-formylfolate; 5-
CH3THF =5-methyltetrahydrofolate; 5-
CHOTHF =5-formyltetrahydrofolate;
5,10-CH2THF= I0-methylene-
tetrahydrofolate; folate(glu)n
=corresponding folate polyglutamate
where n=number of additional
glutamate residues.
Chemicals
All chemicals used were of Analar grade or its
equivalent. 2-[14C]-folic acid (Sp. Radioact. 50-
60mCi M-1) and 3',5',7,9-[3H]-folic acid (Sp.
Radioact. 500mCimM 1) were obtained from the
Radiochemical Centre, Amersham, Bucks.
Compounds for calibration purposes were obtained
as follows: 5-CH3THF was purchased from Eprova
Research Laboratories (Basle, Switzerland) and FA
from Koch Light Laboratories Ltd (Colnbrook,
Bucks); 5-CHOTHF was a gift from Lederle
Laboratories (Gosport, Hants); 10-CHOFA was
prepared by the method of Blakley (1959) and 10-
CHOTHF by the method of Rowe (1971).
Authentic folate polyglutamate derivatives were
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(i) FA(glu), (n =3, 4 and 5) by the method of
Godwin et al. (1972).
(ii) 10-CHOFA(glu). (n =3, 4 and 5) by formylation
of the corresponding FA(glu). according to the
method of Blakley (1959).
(iii) 5-CH3THF(glu). (n=3 and 4) from the
corresponding FA(glu). according to Blair &
Saunders (1970).
Results
Tlissue autolysis experiments
(a) Liver. Sephadex G15 chromatography separated
the radioactivity in the autolysed liver samples
into 3 dual-labelled peaks eluting at tube
numbers 11 (Peak I), 20 (Peak II) and 34 (Peak
III). These are the elution positions of folate
polyglutamates, formylfolates (lO-CHOFA + 10-
CHOTHF) and 5-CH3THF respectively. The
identity of peaks II and III was confirmed by co-
chromatography with authentic markers on
DEAE-cellulose. As the incubation time
increased the proportion of radioactivity present
as folate polyglutamates fell and that as 5-
CH3THF increased until, at the end of the
experiment, 5-CH3THF was the dominant
species representing >70% of the radioactivity
(Table II).
(b) Gut: Sephadex G15 chromatography of
autolysed gut extracts showed the presence of
peaks II and III only. No polyglutamates were
detected at any time. The presence of formyl
folates and 5-CH3THF was again confirmed by
rechromatography of peaks II and III on DEAE-
cellulose. In this case there was little change with
time, equilibrium between the folates being
established rapidly. In contrast to the liver,
formyl folates were the major monoglutamates
formed (Table III). Some breakdown of labile
folates to scission products is indicated by the
excess [3H] associated with peak II (probably p-
aminobenzoyl-L-glutamate) and the excess ["4C]
associated with peak III (possibility a pterin).
These single-labelled peaks separated on
rechromatography on DEAE-cellulose. The
position of the [3H] component was consistent
with its identity as p-aminobenzoyl-L-glutamate.
(c) Tumour (Walker 256 carcinosarcoma): No intact
folates were found autolysed tumour extracts at
any time. Chromatography on Sephadex G15
and DEAE-cellulose showed the presence of
[3H]H20, [3H]-p-aminobenzoyl-L-glutamate,
one other [3H] species and an unidentified
compound labelled with [14C] only. This
suggests there has been considerable breakdown
of the folate in tumour tissue.
Identification oftissuefolates
Sephadex Gi5 chromatography showed
polyglutamate synthesis to be complete 10h after
the administration of folic acid. DEAE-cellulose
chromatography of the folate polyglutamate peak
separated on G15 showed the presence of 3 dual-
labelled species (A, B and C). Folate polyglutamates
A and B were incompletely resolved and eluted
between 0.4M and 0.6M NaCl while polyglutamate
C eluted between 0.8-1.00 M NaCl. In most cases
variable amounts of single-labelled species including
pterin, were present indicating that some
breakdown occurred during handling.
Folate polyglutamate A (the earliest eluting
species) co-chromatographed on DEAE-cellulose
with the authentic 10-CHOFA(glu)4 and
corresponds to the species isolated from rat liver
and identified as such by Connor & Blair (1980).
Folate polyglutamate B eluted from DEAE-
cellulose in the region of the 5-CH3THF derivatives
Table II The distribution of radioactivity in autolysed liver extracts
% Total radioactivity*
lime of Peak Peak Peak
incubation I II III
(min) 14C 3H 14C 3H 14C 3H
0 54.4 48.8 25.1 29.7 14.9 13.8
15 35.0 39.4 40.4 42.7 17.4 8.8
30 21.2 20.9 26.7 31.9 47.2 42.3
60 11.0 10.3 18.0 22.6 61.4 57.2
90 5.3 4.8 18.4 24.1 67.9 59.7
120 4.0 3.9 14.9 18.9 73.5 70.2
*The results are expressed as the percentage of total radioactivity
associated with each peak.
Peak I folate polyglutamates; Peak II formyl folates; Peak III-5-
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Table III The distribution of radioactivity in autolysed gut extracts
% Total radioactivity*
Time of Peak Peak Peak
incubation I II III
(min) 14C 3H 14C 3H 14C 3H
0 nd nd 26.2 57.4 63.6 37.8
15 nd nd 51.8 63.6 39.5 33.5
30 nd nd 59.7 62.2 38.4 30.9
60 nd nd 64.6 69.8 32.1 25.6
120 nd nd 55.9 78.8 31.6 14.3
*The results are expressed as the percentage of total radioactivity
associated with each peak.
nd not detected; Peak I folate polyglutamates; Peak II-formyl folates;
Peak III 5-CH3THF.
and co-chromatographed with 5-CH3THF(glu)3 on
HPLC.
Folate polyglutamate C exhibited marked lability
and was not detected unless precautions were taken
to prevent breakdown during chromatography.
Rechromatography on HPLC was not possible
because of its instability. It failed to chromatograph
with 5-CH3THF(flu)4 or FA(glu)4 and no change
was observed following NaBH4 treatment
suggesting that folate polyglutamate C is not a 5,10-
CH2THF derivative. The considerable lability of
folate polyglutamate C and the detection of pterin,
an oxidation product of THF (Blair & Pearson,
1974) suggest that it may be a THF polyglutamate.
This is supported by Shin et al. (1972) who
identified a THF polyglutamate in rat liver; a
species exhibiting very similar chromatographic
properties on DEAE-cellulose to folate
polyglutamate C.
Tissue distribution of folate polyglutamates: All 3
species were present in liver up to 11 days after the
administration of labelled folic acid. A and B were
present in approximately equal amounts whereas C
was the minor species. However the levels of B 5-
CH3THF(glu)3 were reduced in the intestinal
extract at 24h and B was absent from both types of
tumour tissue at this time.
At earlier time periods (2-6h) labelled folate
monoglutamates were present in the tissue extracts.
Folic acid and 5-CH3THF were identified in all 3
tissues; 10-CHOTHF was present in gut and
tumour extracts but was not detected in liver.
Discussion
These studies again show differing patterns of folate
coenzymes in different tissues. During the autolysis
experiments conjugase released from the lysosomes
hydrolyses the folate polyglutamates to
monoglutamates and an equilibrium is set up
determined by the balance of folate-metabolising
enzymes in that tissue. The rapid destruction of the
polyglutamates in gut and tumour extracts
presumably reflects greater lysosome fragility since
all 3 tissues were shown to contain principally
polyglutamate after 10h when conjugase was
rapidly inactivated by heat. The pattern of
monoglutamates at equilibrium was markedly
different in the 3 tissues examined. The 5-
CH3THF:10-CHO folate ratio of 4.7:1 for the liver
was reversed in the gut to 1:3.9 and the major
monoglutamate formed in tumour tissue was a very
labile species possibly THF. There is also evidence
of a greater amount of this species in the gut than
the liver.
The folate polyglutamates identified by direct
analysis were l0-CHOFA(glu)4, 5-CH3THF(glu)3
and possibly THF(glu)n. These observations agree
with the isolation of 10-CHOFA(glu)4 from rat liver
(Connor & Blair, 1980) and the detection of 5-
CH3THF polyglutamates (Shin et al., 1972; Hillman
et al., 1977) and THF(glu)4 (Wittwer & Wagner,
1980) by others. Again there was a difference in the
balance of these folates in the 3 tissues studied. In
the tumour tissue and to a lesser extent the gut,
there was a shift away from 5-CH3THF(glu)3 in
favour of 10-CHOFA(glu)4. Some of this is
presumably 10-CHOTHF(glu)4 in vivo since
identification of 10-CHOFA(glu)4 has been
attributed to the oxidation of 10-CHOTHF(glu)4
during extraction and analysis (Connor & Blair,
1980). This shift away from 5-methyl forms of folate
in favour of formyl folates or THF derivatives in
the tumour and gut is consistent with the results of
autolysis experiments and with the detection of 10-
CHOTHF at early time periods in gut and tumour
but not liver. It also explains the increased levels of
10-CHOTHF in the plasma of humans suffering
from malignant disease (Ratanasthien et al., 1977)FOLATES IN NORMAL AND MALIGNANT TISSUES 397
and in the urine of rats bearing the Walker 256
carcinosarcoma (Barford & Blair, 1978). These
changes may reflect the differing requirement for
purine and pyrimidine synthesis in the tissues
examined. As these tissues have different
proliferation rates these changes in folate coenzyme
distribution may be related to tissue proliferation.
The Walker 256 carcinosarcoma in cell culture
shows methionine auxotrophy (Halpern et al., 1974)
which cannot be explained by the lack of
methionine synthetase (Hoffman & Erbe, 1976). In
these experiments no 5-CH3THF derivatives were
found in Walker 256 carcinosarcoma extracts except
shortly after administration of FA. This offers an
explanation of the methionine auxotrophy since no
methionine can be synthesised in the absence of the
appropriate coenzyme and all folate entering the
tumour appears to be channelled away from 5-
CH3THF.
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